HEALTH CATALYST, INC. (HCAT): Price and Financial Metrics


Today's Latest Price: $36.04 USD

0.47 (1.32%)

Updated Nov 27 1:00pm

Add HCAT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

HCAT Stock Summary

  • HCAT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.52 -- higher than only 6.33% of US-listed equities with positive expected earnings growth.
  • HCAT's went public 1.35 years ago, making it older than merely 1.5% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of 262.94%, Health Catalyst Inc's debt growth rate surpasses 94.13% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Health Catalyst Inc are FEYE, SVMK, LPSN, CLXT, and DMRC.
  • Visit HCAT's SEC page to see the company's official filings. To visit the company's web site, go to

HCAT Stock Price Chart Interactive Chart >

Price chart for HCAT

HCAT Price/Volume Stats

Current price $36.04 52-week high $41.26
Prev. close $35.57 52-week low $17.48
Day low $35.52 Volume 141,100
Day high $36.22 Avg. volume 621,885
50-day MA $35.13 Dividend yield N/A
200-day MA $31.06 Market Cap 1.53B


Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. The company is headquartered in Salt Lake City, Utah.

HCAT Latest News Stream

Event/Time News Detail
Loading, please wait...

HCAT Latest Social Stream

Loading social stream, please wait...

View Full HCAT Social Stream

Latest HCAT News From Around the Web

Below are the latest news stories about Health Catalyst Inc that investors may wish to consider to help them evaluate HCAT as an investment opportunity.

Health Catalyst - Looks Cheap But Where Is The Catalyst?

I covered Health Catalyst (HCAT) when the company went public in the summer of last year. At the time of the offering, I noted that the company seems an interesting play to bet on health care improvements as the company combines data, technology and experts, resulting in rapid growth of...

The Value Investor on Seeking Alpha | August 30, 2020

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2020 Results - Earnings Call Transcript

Health Catalyst, Inc. (HCAT) Q2 2020 Earnings Conference Call Aug 11, 2020 5:00 PM ET Company Participants Adam Brown - SVP, IR Dan Burton - CEO Patrick Nelli - CFO Conference Call Participants Robert Jones - Goldman Sachs Anne Samuel - JPMorgan Ryan Daniels - William Blair Sean Wieland -...

SA Transcripts on Seeking Alpha | August 12, 2020

Health Catalyst to Announce Second Quarter 2020 Operating Results and Host Conference Call on Tuesday, August 11, 2020

SALT LAKE CITY, July 29, 2020 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics…

GlobeNewswire | July 29, 2020

How Much Of Health Catalyst, Inc. (NASDAQ:HCAT) Do Insiders Own?

Every investor in Health Catalyst, Inc. (NASDAQ:HCAT) should be aware of the most powerful shareholder groups...

Yahoo | July 23, 2020

Health Catalyst's Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Health Catalyst.

Yahoo | July 23, 2020

Read More 'HCAT' Stories Here

HCAT Price Returns

1-mo 4.52%
3-mo 15.59%
6-mo 31.68%
1-year -9.29%
3-year N/A
5-year N/A
YTD 3.86%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8347 seconds.